GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:AIMT
Delisted

Aimmune Therapeutics Stock Price (Quote)

$34.49
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $34.49 $34.49 Friday, 27th May 2022 AIMT stock ended at $34.49. During the day the stock fluctuated 0% from a day low at $34.49 to a day high of $34.49.
90 days $34.49 $34.49
52 weeks $34.49 $34.49

Historical Aimmune Therapeutics prices

Date Open High Low Close Volume
2020-08-14 $13.87 $14.01 $13.57 $13.65 679 133
2020-08-13 $14.23 $14.63 $13.96 $13.99 643 086
2020-08-12 $14.10 $14.38 $13.72 $14.36 1 116 449
2020-08-11 $13.86 $14.55 $13.71 $13.91 834 878
2020-08-10 $13.85 $14.07 $13.69 $13.79 617 047
2020-08-07 $13.78 $13.86 $13.54 $13.77 583 585
2020-08-06 $13.49 $13.93 $13.35 $13.78 820 095
2020-08-05 $14.00 $14.01 $13.25 $13.52 1 479 815
2020-08-04 $14.40 $14.68 $13.61 $13.84 1 631 907
2020-08-03 $13.27 $13.77 $13.22 $13.61 1 029 670
2020-07-31 $13.90 $13.93 $12.78 $13.21 2 216 164
2020-07-30 $13.70 $14.34 $13.70 $14.04 801 101
2020-07-29 $14.06 $14.24 $13.50 $13.80 1 298 389
2020-07-28 $14.76 $14.80 $14.10 $14.11 705 780
2020-07-27 $14.55 $14.66 $14.34 $14.64 950 907
2020-07-24 $14.63 $14.88 $14.23 $14.52 924 652
2020-07-23 $15.51 $15.53 $14.56 $14.81 1 372 368
2020-07-22 $15.50 $15.75 $15.44 $15.60 572 800
2020-07-21 $16.11 $16.16 $15.51 $15.52 875 600
2020-07-20 $16.00 $16.24 $15.29 $15.96 805 300
2020-07-17 $16.34 $16.47 $15.91 $15.95 514 700
2020-07-16 $16.70 $16.76 $16.02 $16.33 680 300
2020-07-15 $16.36 $16.85 $16.21 $16.80 969 100
2020-07-14 $15.40 $15.96 $15.18 $15.95 868 000
2020-07-13 $16.30 $16.42 $15.49 $15.53 1 029 900
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT